Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as AnticancerAgentPreeti Patel, Vivek Asati, Balak Das Kurmi et al.|Current Cancer Drug Targets|2022Cited by 40
Novel VEGFR‐2 Kinase Inhibitors as Anticancer Agents: A Review Focusing on SAR and Molecular Docking Studies (2016–2021)S. Vishakha, Preeti Patel, Kumari Kajal et al.|Chemistry & Biodiversity|2023Cited by 24
Current Trends in the Development of EGFR Inhibitors as Promising AnticancerAgents: Sar and Synthetic Studies from (2010-2020)Sitanshu Mondal, Preeti Patel, S. Vishakha et al.|Current Organic Chemistry|2023Cited by 3
Physiochemical Investigations of Surface Active Ionic Liquids Containing Salicylate Moiety; Enhanced Pharmacological Behaviour and PermeabilityNeha Sharma, Reshu Sanan, Rakesh Kumar Mahajan et al.|ChemistrySelect|2025Cited by 0